Cambridge Healthtech Institute’s Thirteenth Annual Biomarkers and Immuno-Oncology World Congress is the longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. With the promising developments in immuno-oncology over the past five years, much of the biomarker R&D has shifted to discovery and development of predictive biomarkers for immunotherapy patient stratification, understanding tumor mutational load and neoantigens in developing personalized immunotherapy approaches, using biomarker or mechanism data to choose rational combination immunotherapy, and applying immune profiling to predict response to immunotherapy.
The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. Now in its thirteenth year, the Biomarkers and Immuno-Oncology World Congress is the leading annual meeting dedicated to biomarkers, diagnostics, and immuno-oncology research and implementation that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall.
SHORT COURSES*
- MONDAY AFTERNOON, MAY 1 | 1:00 – 4:00 PM
- SC1: FIT-FOR-PURPOSE BIOMARKER ASSAY DEVELOPMENT AND VALIDATION
- MONDAY EVENING, MAY 1 | 5:00 – 8:00 PM
- Dinner Workshop. SC2: LIQUID BIOPSY FOR IMMUNO-ONCOLOGY AND PRECISION MEDICINE
- Dinner Short Course. SC3: PREPARING FOR COMPANION DIAGNOSTIC DEVICE STUDIES AND SUBMISSIONS TO FDA
- TUESDAY EVENING, MAY 2 | 6:00 – 9:00 PM
- Dinner Short Course. SC4: NEXT-GENERATION SEQUENCING AS A CLINICAL TEST
- Dinner ThinkTank. SC5: PD-L1 ASSAYS FOR BIOMARKERS AND COMPANION DIAGNOSTICS
- WEDNESDAY EVENING, MAY 3 | 6:15 – 9:15 PM
- Dinner Executive ThinkTank. SC6: COMPLEMENTARY DIAGNOSTICS
- Dinner Short Course. SC7: IMMUNE MONITORING IN CANCER
More Information: biomarkerworldcongress.com
